Results 31 to 40 of about 254,699 (197)

Intrathecal cytomegalovirus immunoglobulin for CMV encephalitis post allogeneic stem cell transplantation

open access: yesIDCases, 2022
We report the outcome of a 43 year old man who developed fatal ventriculoencephalitis due to cytomegalovirus (CMV) infection 7 months post allogeneic stem cell transplant.
Ian Pang   +5 more
doaj   +1 more source

Intravenous immunoglobulins: a treatment for Alzheimer's disease? [PDF]

open access: yesJournal of Neurology, Neurosurgery & Psychiatry, 2004
A novel therapeutic option for Alzheimer’s disease Aβ-peptide is generally considered to play a central role in the pathogenesis of Alzheimer’s disease (AD). The peptide is cleaved from amyloid precursor protein (APP) by secretases and is a key component of the amyloid plaques.
Hack, C. E., Scheltens, P.
openaire   +2 more sources

Anti-Inflammatory and Immunomodulatory Effect of High-Dose Immunoglobulins in Children: From Approved Indications to Off-Label Use

open access: yesCells, 2023
Background: The large-scale utilization of immunoglobulins in patients with inborn errors of immunity (IEIs) since 1952 prompted the discovery of their key role at high doses as immunomodulatory and anti-inflammatory therapy, in the treatment of IEI ...
Francesca Conti   +14 more
doaj   +1 more source

Kawasaki disease shock syndrome rescued by a combination of extracorporeal membrane oxygenation, steroids, and intravenous immunoglobulin [PDF]

open access: yesPediatric Emergency Medicine Journal, 2022
Kawasaki disease shock syndrome (KDSS) is defined as a sustained decrease in systolic blood pressure or signs of poor perfusion. Some children with KDSS are refractory to conventional therapy, such as intravenous immunoglobulin (IVIG).
Chanyoung Chung   +4 more
doaj   +1 more source

Intravenous immunoglobulins-associated eczematous reactions occur with a broad range of immunoglobulins types and preferentially in patients with neurologic disorders: a French national multicenter study

open access: yes, 2022
supplemental data concerning our study "Intravenous immunoglobulins-associated eczematous reactions occur with a broad range of immunoglobulins types and preferentially in patients with neurologic disorders: a French national multicenter study" ...
VOLAND, P (via Mendeley Data)
core   +3 more sources

Intravenous immunoglobulins in children with new onset dilated cardiomyopathy [PDF]

open access: yes, 2017
Background: Dilated cardiomyopathy is a rare but serious disorder in children. No effective diagnostic or treatment tools are readily available. This study aimed to evaluate the efficacy of intravenous immunoglobulins in children with new onset dilated ...
Dalinghaus, Michiel   +11 more
core   +1 more source

Adjuvant treatment of severe varicella pneumonia with intravenous varicella zoster virus-specific immunoglobulins

open access: yesInternational Journal of Infectious Diseases, 2019
Varicella zoster virus (VZV) pneumonia is associated with significant mortality, especially in the immunocompromised host. VZV-specific immunoglobulins (VZIG) are currently used as post-exposure prophylaxis for at-risk patients, but not as adjunctive ...
Davide Mangioni   +5 more
doaj   +1 more source

INTRAVENOUS IMMUNOGLOBULIN APPLICATION IN CLINICAL PRACTICE

open access: yesПедиатрическая фармакология, 2013
The article gives data on the structure and function of immunoglobulins. Given the multitude of mechanisms of their action, indications to their use are constantly expanding.
T. V. Latysheva, E. A. Latysheva
doaj   +1 more source

Continuous increase of immunoglobulin therapy in Iceland

open access: yesClinical Immunology Communications, 2022
Background: The use of immunoglobulin treatment has been increasing for various indications. The objective of this study was to evaluate clinical use of immunoglobulin therapy in Iceland, estimate off-label usage and describe possible changes in this ...
Valgeir Steinn Runólfsson   +5 more
doaj   +1 more source

Subcutaneous immunoglobulin in treating inflammatory neuromuscular disorders

open access: yesTherapeutic Advances in Neurological Disorders, 2015
Objective: Intravenous immunoglobulin administration has long been used in the treatment of autoimmune neuromuscular disorders. Immunoglobulins may be administered by intramuscular, intravenous or subcutaneous routes.
Min-Suk Yoon   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy